Cardiology
Cardiovascular disease is the most common cause of death and has the highest costs for drug treatment in Sweden. For more than 25 years, the Cardiology research group has been a national centre for research and development in coronary artery disease and its complications, and in recent years stroke prevention during atrial fibrillation.
Description of our research
The research includes register based studies, cell biology research and large clinical trials with patients and healthy controls from many countries.
We aim to improve the treatment and management for the individual patient. We work in the following areas:
- Disease prevalence and mechanisms of disease throughepidemiologic studies of registries and cohort and pathophysiology studies.
- Diagnosis, risk assessment and precision medicine through biomarker studies and studies on imaging based diagnosis.
- Assessment of old (and new) therapies through international clinical trials, independent registry based randomized clinical trials as well as observational registry- and cohort studies.
- Implementation of new therapies through observational registry studies.
Group members
Publications
Part of International Journal of Cardiology, p. 132698, 2025
Asundexian versus Apixaban in Patients with Atrial Fibrillation.
Part of New England Journal of Medicine, p. 23-32, 2025
Part of BMJ Open, 2025
Part of European Heart Journal - Quality of Care and Clinical Outcomes, p. 723-736, 2024
Ischemic Stroke in Adults With Congenital Heart Disease: Cumulative Incidence and Associated Factors
Part of Journal of the American Heart Association, 2024
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation
Part of Circulation, p. 1090-1100, 2024
Symptoms during pregnancy in primiparous women with congenital heart disease
Part of Scandinavian Cardiovascular Journal, 2024
Unwrapping phase contrast MRI by iterative graph cuts
Part of Magnetic Resonance in Medicine, p. 1484-1495, 2024
Part of Journal of the American Heart Association, 2024
Part of European Heart Journal - Quality of Care and Clinical Outcomes, 2024
Part of European Heart Journal - Quality of Care and Clinical Outcomes, p. 386-390, 2024
Part of Structural Heart, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
Part of Journal of the American College of Cardiology, p. 1627-1636, 2024
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction
Part of New England Journal of Medicine, p. 1481-1492, 2024
Part of Open heart, 2024
Part of Acta Obstetricia et Gynecologica Scandinavica, p. 970-979, 2024
Temporal biomarker concentration patterns during the early course of acute coronary syndrome
Part of Clinical Chemistry and Laboratory Medicine, p. 1167-1176, 2024
Part of European Heart Journal, p. 559-562, 2024
- DOI for Cardiovascular medications, high-sensitivity cardiac troponin T concentrations, and long-term outcome in non-ST segment elevation acute coronary syndrome
- Download full text (pdf) of Cardiovascular medications, high-sensitivity cardiac troponin T concentrations, and long-term outcome in non-ST segment elevation acute coronary syndrome
Part of British Journal of Haematology, p. 1740-1751, 2024
Part of European Journal of Epidemiology, p. 35-49, 2024
Part of American Heart Journal, p. 1-10, 2024
- DOI for Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
- Download full text (pdf) of Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
Part of The Lancet, p. 1750-1759, 2024
Obituary: Arthur E. Weyman, 1941-2024
Part of European Heart Journal Cardiovascular Imaging, p. 1183-1185, 2024
Part of Open heart, 2024
- DOI for Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study
- Download full text (pdf) of Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study
Analysis of plasma metabolomes from 11 309 subjects in five population-based cohorts.
Part of Scientific Reports, p. 8933, 2024
Part of Circulation, 2024
Part of Circulation, p. 1065-1086, 2024
Part of Journal of the American Heart Association, 2024
- DOI for Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
- Download full text (pdf) of Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
Part of Journal of the American Heart Association, 2024
Part of Journal of the American College of Cardiology, p. 1528-1540, 2024
Part of American Journal of Cardiology, p. 118-124, 2024
Part of JACC. Advances, p. 101088, 2024
Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein
Part of Scientific Reports, 2024
Part of Contemporary Clinical Trials Communications, 2024
Part of British Journal of Sports Medicine, 2024
Breastfeeding in primiparous women with congenital heart disease: a register study
Part of International Breastfeeding Journal, 2024
Part of Scandinavian Cardiovascular Journal, 2024
Part of European Heart Journal Open, 2024
Part of Journal of the American Heart Association, 2024
- DOI for Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
- Download full text (pdf) of Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.
Part of NEJM evidence, 2024
Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure
Part of European Heart Journal - Cardiovascular Pharmacotherapy, p. 91-92, 2024
Part of Journal of the American Heart Association, 2024
- DOI for Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF
- Download full text (pdf) of Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF
Part of Open heart, p. 1-8, 2024
[Spontaneous coronary artery dissection and physical activity - what we know and don't know].
Part of Läkartidningen, 2024
Time to childbirth and assisted reproductive treatment in women with congenital heart disease
Part of Open heart, 2024
Part of Circulation, p. 1837-1846, 2024
Part of Diabetologia, 2024
Part of Circulation. Cardiovascular Interventions, 2024
Part of Diabetes Care, 2024
Part of European Journal of Cardiovascular Nursing, 2024